2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
250
Leukemia
186
Lymphoma
137
Leukemia, Myeloid, Acute
103
Burkitt Lymphoma
90
Myelodysplastic Syndromes
79
Lymphoma, Non-Hodgkin
65
Breast Neoplasms
60
Lymphoma, Large B-Cell, Diffuse
59
Leukemia, Lymphocytic, Chronic, B-Cell
49
Lymphoma, Mantle-Cell
47
Hodgkin Disease
47
Graft vs Host Disease
46
Lymphoma, Follicular
45
Leukemia, Myeloid, Accelerated Phase
45
Multiple Myeloma
39
Leukemia, Myeloid, Chronic-Phase
39
Congenital Abnormalities
39
Myeloproliferative Disorders
38
Blast Crisis
38
Leukemia, Myelomonocytic, Chronic
37
Leukemia, Biphenotypic, Acute
35
Recurrence
34
Lymphoma, Large-Cell, Immunoblastic
33
Lymphoma, B-Cell, Marginal Zone
31
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
30
Osteosarcoma
29
Primary Myelofibrosis
27
Neoplasms, Plasma Cell
25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Interventions
Dexamethasone
13
Bortezomib
8
Cyclophosphamide
6
Lenalidomide
5
pomalidomide
3
isatuximab
3
glucarpidase
3
Kidney Transplantation
3
Calcium Dobesilate
3
Thalidomide
2
Paclitaxel
2
Gemcitabine
2
Carboplatin
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
Azacitidine
2
vinflunine
1
veliparib
1
trifluridine tipiracil drug combination
1
trebananib
1
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
rubitecan
1
ripretinib
1
regorafenib
1
pevonedistat
1
pembrolizumab
1
osimertinib
1
mirabegron
1
melflufen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Methotrexate
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts